Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-02-17Clinical Trial Update: Replicor Compassionate Access Program
Replicor's compassionate access program for hepatitis B and hepatitis D, along with related liver diseases, is no longer available.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: The Treatment of Hepatocirrhosis and Portal Hypertension [NA]
This clinical trial update reports a completed study on treatments for liver cirrhosis and portal hypertension.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients
The completed study from Tanta University analyzed serum zinc and magnesium levels in patients with chronic liver disease and cirrhosis.
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement [NA]
A clinical trial update describing a study that assesses cardiac function using MRI and echocardiography in patients with alcohol-related li…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients with Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome [Phase 3]
This Phase 3 clinical trial investigates a nutritional intervention for sarcopenia in patients with liver cirrhosis and refractory ascites w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: AGRA Before and After Liver Transplantation
Clinical trial update on AGRA evaluating outcomes before and after liver transplantation in patients with liver cirrhosis; the study is acti…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis [Phase 2, Phase 3]
ClinicalTrials.gov listing for a Phase 2/3 trial comparing dabigatran to enoxaparin in patients with portal vein thrombosis and cirrhosis, n…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Comparison of Safety and Efficacy of Tailored Versus Fixed Dose Albumin for the Management of Patients With Cirrhosis and Sepsis Associated Acute Kidney Injury [NA]
Clinical trial update comparing tailored versus fixed-dose albumin for cirrhosis with sepsis-associated acute kidney injury; currently not r…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: A Study of the Intestinal Microbiome in Patients with Cirrhosis
A clinical trial sponsored by Yonsei University is investigating the intestinal microbiome in patients with liver cirrhosis and is currently…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Faecal Microbiota Transplantation for Liver Cirrhosis [Phase 2, Phase 3]
Clinical trial update on faecal microbiota transplantation for liver cirrhosis, currently recruiting in Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment [Phase 1]
Phase 1 pharmacokinetic study evaluating tipranavir/ritonavir, ribavirin, and pegylated interferon in subjects with mild hepatic impairment …
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Liver and Spleen Stiffness to Predict the Presence of Esaphageal Varices in Cirrhotic With Advanced HCC
This clinical trial investigates whether measurements of liver and spleen stiffness can predict the presence of esophageal varices in patien…
-
EMA withdrawal · 2025-01-20EMA Revoked: Ocaliva (obeticholic acid) — Advanz Pharma Limited
EMA revoked the marketing authorization for Ocaliva (obeticholic acid) held by Advanz Pharma Limited, effective 16 April 2024, for biliary/l…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients with Cirrhosis
Clinical trial evaluating the MSEPT9 biomarker for predicting hepatocellular carcinoma occurrence in patients with cirrhosis; the study is n…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation [NA]
A clinical trial assessing fecal microbiota transplantation to prevent infectious complications after orthotopic liver transplantation.
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Posterior Wall Sparing of Laparoscopic Cholecystectomy in Cirrhotic Patients
This clinical trial evaluates posterior wall-sparing laparoscopic cholecystectomy in patients with cirrhosis and cholecystitis. The study st…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Coagulation in Cirrhosis [Phase 4]
A Phase 4 clinical trial on coagulation in liver cirrhosis, sponsored by the Medical University of Vienna, is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Study of Oxidized Albumin in Liver Transplant Patients
A clinical trial evaluating oxidized albumin in liver transplant patients; the study is currently NOT_YET_RECRUITING in Region Stockholm.
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Thalidomide Versus Argon Plasma Coagulation in Gastric Antral Vascular Ectasia(GAVE)-Related Anaemia in Cirrhosis (TAG Trial) [NA]
A clinical trial comparing thalidomide versus argon plasma coagulation for gastric antral vascular ectasia-related anemia in cirrhosis, curr…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Spirulina Tablets Treat Liver Fibrosis/Cirrhosis [NA]
This update indicates that spirulina is being studied for liver fibrosis and liver cirrhosis, and the trial is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation
A clinical trial update describing a study that compares the incidence of delirium in liver transplant patients when different anesthetic ag…
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Evaluation of Chronic Liver Disease Condition and Transplant Prognosis Assisted by Eye Biological Parameters
A clinical trial is recruiting to evaluate whether eye-based biomarkers can help assess chronic liver disease and predict transplant prognos…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Radiological Spectrum Of Fatty Liver Correlate With High Resolution Ultrasonography Of Fibrosis And Cirrhosis
Clinical trial update examining how high-resolution ultrasound findings correlate with fibrosis and cirrhosis in fatty liver disease.
-
FDA approval · 2024-12-27FDA Approved: BUMETANIDE — Original Application (Advagen Pharma Limited)
FDA approved Advagen Pharma Limited's original ANDA for bumetanide, a loop diuretic used to treat edema associated with congestive heart fai…
-
FDA approval · 2024-12-13FDA Approved: FUROSEMIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for furosemide, enabling a generic version of the loop diuretic to be marketed.